Application of Lipidomics to Exploratory Discovery in Metabolic Diseases
Overview
Join us for a deep dive into lipidomics, exploring its power to unlock the mysteries of metabolic disease.
Lipids: These ubiquitous molecules are far more than just stored energy. They govern cellular signalling, structure, and function, holding the key to understanding diverse metabolic dysfunctions. But the sheer complexity of the lipidome, with its thousands of species, presents a formidable analytical challenge.
Presented by Natalie Daurio a principal scientist at Pfizer and renowned expert in lipidomics research. She will guide you through the intricate world of lipid analysis, offering practical strategies and valuable knowledge.
From Dysregulation to Disease Insights
In this exclusive webinar, you'll:
- Explore the latest advancements in LC-TIMS-MS technology for lipidomics research.
- Gain practical guidance on data acquisition, processing, and interpretation with a focus on biological relevance.
- Discover real-world applications of LC-TIMS-MS in deciphering the mechanisms underlying metabolic disease progression.
Who should attend to this webinar:
- Researchers: Biologists, biochemists, and analytical scientists investigating metabolic diseases, diabetes, obesity, cardiovascular health, and related fields.
- Omicists: Professionals working with mass spectrometry and LC-MS/MS platforms seeking to expand their expertise into lipidomics analysis.
- Graduate students and postdoctoral fellows: Those seeking to gain advanced knowledge and practical skills in lipidomics research methodologies.
- Industry professionals: Scientists and R&D personnel in pharmaceutical, biotechnology, and nutritional companies developing therapeutic and diagnostic solutions related to metabolic health.
Speaker
Natalie Daurio, Ph.D., Principal Scientist, Pfizer, Cambridge, MA, USA
For Research Use Only. Not for use in clinical diagnostic procedures.